We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+37.47%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$343M
AUM Growth
+$44.3M
Cap. Flow
-$16.4M
Cap. Flow %
-4.77%
Top 10 Hldgs %
36.95%
Holding
100
New
31
Increased
17
Reduced
28
Closed
22
Avg Time Held Equity + Options
1.7 quarters
Top 10 Avg Time Held Equity + Options
1 quarter
Top 20 Avg Time Held Equity + Options
1.7 quarters
Avg Time Held Equity only
1.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.8 quarters

Top Buys

Rank Stock Value
1
SOLY
Soliton, Inc.
SOLY
+$10.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$9.42M
3
GLD icon
SPDR Gold Trust
GLD
+$9.03M
4
RCM icon
R1 RCM Inc. Common Stock
RCM
+$7.85M
5
COR icon
Cencora
COR
+$7.79M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$21.5M
2
NVST icon
Envista
NVST
+$12.8M
3
BSX icon
Boston Scientific
BSX
+$10.2M
4
AGN
Allergan plc
AGN
+$9.74M
5
BIIB icon
Biogen
BIIB
+$8.46M

Sector Composition

Rank Sector Weight
1 Healthcare 81.41%
2 Miscellaneous 15.19%
3 Industrials 2.48%
4 Financials 0.92%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CHRS icon
1
Coherus Oncology
CHRS
$165M
$20.3M 5.92%
1,135,863
+58,024
+5% +$982K
2019 Q2
4 quarters
GLD icon
2
SPDR Gold Trust
GLD
$141B
$20.2M 5.9%
120,702
+56,000
+87% +$9.03M
2020 Q1
1 quarter
MCK icon
3
McKesson
MCK
$112B
$14.9M 4.36%
97,285
-35,055
-26% -$5.06M
2019 Q3
3 quarters
TEVA icon
4
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
$11.9M 3.46%
962,796
+390,115
+68% +$4.41M
2020 Q1
1 quarter
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11.7M 3.4%
94,984
-73,060
-43% -$8.29M
2018 Q4
6 quarters
COR icon
6
Cencora
COR
$63B
$10.1M 2.96%
100,545
+84,617
+531% +$7.79M
2019 Q3
3 quarters
MOH icon
7
Molina Healthcare
MOH
$10.9B
$10.1M 2.95%
56,807
+20,834
+58% +$3.55M
2018 Q4
6 quarters
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.88M 2.88%
+90,000
New +$9.42M
2020 Q2
0 quarters
MRK icon
9
Merck
MRK
$350B
$8.84M 2.58%
119,839
+22,288
+23% +$1.68M
2019 Q4
2 quarters
MRSN icon
10
DELISTED
Mersana Therapeutics
MRSN
$8.7M 2.54%
14,871
+8,221
+124% +$2.81M
2019 Q4
2 quarters
RCM icon
11
DELISTED
R1 RCM Inc. Common Stock
RCM
$8.51M 2.48%
+763,023
New +$7.85M
2020 Q2
0 quarters
ELV icon
12
Elevance Health
ELV
$92.2B
$8.37M 2.44%
31,819
-26,050
-45% -$6.95M
2019 Q2
4 quarters
CBAY icon
13
DELISTED
Cymabay Therapeutics
CBAY
$8.03M 2.34%
2,299,982
+2,167,508
+1,636% +$6.25M
2020 Q1
1 quarter
SOLY
14
DELISTED
Soliton, Inc.
SOLY
$7.97M 2.33%
+1,025,000
New +$10.1M
2020 Q2
0 quarters
HCA icon
15
HCA Healthcare
HCA
$99.8B
$7.93M 2.32%
81,732
+3,800
+5% +$395K
2018 Q1
9 quarters
UTHR icon
16
United Therapeutics
UTHR
$23.3B
$7.89M 2.3%
65,210
-25,613
-28% -$2.88M
2018 Q4
6 quarters
LLY icon
17
Eli Lilly
LLY
$1.04T
$7.54M 2.2%
+45,901
New +$7.05M
2020 Q2
0 quarters
MESO icon
18
PUT
Mesoblast
MESO
$1.8B
$7.3M 2.13%
320,600
+316,550
+7,816% +$6.78M
2020 Q1
1 quarter
CAH icon
19
Cardinal Health
CAH
$55.5B
$6.97M 2.03%
+133,500
New +$6.88M
2020 Q2
0 quarters
BMY.RT icon
20
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$6.16M 1.8%
1,719,271
-527,629
-23% -$1.9M
2020 Q1
1 quarter
OFIX icon
21
Orthofix Medical
OFIX
$377M
$6.14M 1.79%
+191,891
New +$6.37M
2020 Q2
0 quarters
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
$5.99M 1.75%
95,153
+10,000
+12% +$550K
2019 Q3
3 quarters
OSUR icon
23
OraSure Technologies
OSUR
$263M
$5.35M 1.56%
+460,000
New +$5.97M
2020 Q2
0 quarters
WBA icon
24
DELISTED
Walgreens Boots Alliance
WBA
$5.26M 1.54%
+124,194
New +$5.27M
2020 Q2
0 quarters
CRIS icon
25
Curis
CRIS
$1.49M
$5.2M 1.52%
+10,750
New +$3.96M
2020 Q2
0 quarters
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Sio Capital Management held 100 positions worth $343M, up 15% from $298M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sio Capital Management withdrew a net $16.4M in Q2 2020, closing 22 positions and reducing 28 holdings. Its most notable exit was Amgen, an estimated $21.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 86% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, Sio Capital Management opened a new position in Soliton, Inc. worth $7.97M.

  • Sio Capital Management's largest Q2 2020 buy was Soliton, Inc.: 1,025,000 shares worth $7.97M.
  • Sio Capital Management added most to SPDR Gold Trust in Q2 2020, an estimated $9.03M increase.
  • Sio Capital Management's biggest Q2 2020 reduction was Boston Scientific, cutting an estimated $10.2M.
  • Sio Capital Management fully exited Amgen in Q2 2020, selling an estimated $21.5M.
  • Sio Capital Management's ten largest holdings make up 37% of its $343M portfolio in Q2 2020.
  • Sio Capital Management opened 31 new positions and closed 22 in Q2 2020.
  • Sio Capital Management's portfolio value rose 15% quarter-over-quarter to $343M.

Based on Sio Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.